Cargando…
Mannich-type modifications of (−)-cannabidiol and (−)-cannabigerol leading to new, bioactive derivatives
(−)-Cannabidiol (CBD) and (−)-cannabigerol (CBG) are two major non-psychotropic phytocannabinoids that have many beneficial biological properties. However, due to their low water solubility and prominent first-pass metabolism, their oral bioavailability is moderate, which is unfavorable for medicina...
Autores principales: | Lőrincz, Eszter Boglárka, Tóth, Gergely, Spolárics, Júlia, Herczeg, Mihály, Hodek, Jan, Zupkó, István, Minorics, Renáta, Ádám, Dorottya, Oláh, Attila, Zouboulis, Christos C., Weber, Jan, Nagy, Lajos, Ostorházi, Eszter, Bácskay, Ildikó, Borbás, Anikó, Herczegh, Pál, Bereczki, Ilona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638401/ https://www.ncbi.nlm.nih.gov/pubmed/37949940 http://dx.doi.org/10.1038/s41598-023-45565-7 |
Ejemplares similares
-
Synthesis of an amphiphilic vancomycin aglycone derivative inspired by polymyxins: overcoming glycopeptide resistance in Gram-positive and Gram-negative bacteria in synergy with teicoplanin in vitro
por: Szűcs, Zsolt, et al.
Publicado: (2022) -
Pharmacological Evaluation of Newly Synthesized Cannabidiol Derivates on H9c2 Cells
por: Szőke, Kitti, et al.
Publicado: (2023) -
Synthesis of Antiviral Perfluoroalkyl Derivatives of Teicoplanin and Vancomycin
por: Bereczki, Ilona, et al.
Publicado: (2020) -
The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin
por: Bereczki, Ilona, et al.
Publicado: (2022) -
Reprogramming of the Antibacterial Drug Vancomycin Results in Potent Antiviral Agents Devoid of Antibacterial Activity
por: Szűcs, Zsolt, et al.
Publicado: (2020)